HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans - Wikidata - awgldk - TriplyDB

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

http://www.wikidata.org/entity/Q34172669

about

Genetic testing for prevention of severe drug-induced skin rash Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing Drug induced exfoliative dermatitis: state of the art Challenges, Solutions, and Quality Metrics of Personal Genome Assembly in Advancing Precision Medicine Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.Idiosyncratic adverse drug reactions: current concepts The search for circulating epilepsy biomarkers Drug allergy: causes and desensitization Pharmacogenomics of adverse drug reactions Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions Review of Toxic Epidermal Necrolysis Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizes ABC transporters and the proteasome complex are implicated in susceptibility to Stevens-Johnson syndrome and toxic epidermal necrolysis across multiple drugs The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects Genetics and genomics in Thailand: challenges and opportunities A genome-wide association study and biological pathway analysis of epilepsy prognosis in a prospective cohort of newly treated epilepsy Human leucocyte antigen-adverse drug reaction associations: from a perspective of ethnicity.Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management.HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.Pharmacogenomics of off-target adverse drug reactions.Cutaneous adverse drug reactions in Indian population: A systematic review.Imputing amino acid polymorphisms in human leukocyte antigens.Identification of risk factors for carbamazepine-induced serious mucocutaneous adverse reactions: A case-control study using data from spontaneous adverse drug reaction reports.Replication and cross-phenotype study based upon schizophrenia GWASs data in the Japanese population: support for association of MHC region with psychosis.Japan PGx Data Science Consortium Database: SNPs and HLA genotype data from 2994 Japanese healthy individuals for pharmacogenomics studies.Stevens-Johnson Syndrome following Failure of Genetic Screening prior to Carbamazepine Prescription.Genotyping for severe drug hypersensitivity.HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions HLA diversity in the 1000 genomes dataset.Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.Pharmacogenomics: Current State-of-the-Art Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications.

P2860

Q24202114-3F544198-302C-4829-9A54-692AEC7D8BDB Q24626941-5686D45F-1BA4-4BA6-B962-16D846444961 Q26739886-34298945-011A-4D17-B729-ED06A3250E94 Q26750544-3CB56E73-473D-472F-B4EB-4FF4ADACC7C6 Q26781892-136A32DB-41DB-4B03-A038-E00C2C29C8F2 Q26800976-91D0DD0A-3937-49C7-B7A1-52EF0A2FF96A Q26800980-D9E87959-3161-40BC-A6BA-84F7447E5E02 Q26824391-415060C0-20EB-450B-A022-EC252C21F676 Q26851663-B6B2D5EA-AC1B-4F46-9E96-D94DCCDE671D Q27012238-5DA9FDD8-1E6C-4A2E-AFF5-3F980700F66C Q27015820-ABFC2EAE-6723-4C83-A336-87F1F00E281B Q27690772-05744EF4-320E-490F-A5DF-254FB25B6CB5 Q27692095-C19C9D98-9C1C-4EB1-849D-D40C8206DC6C Q28066096-68E8EA65-0F5C-4087-A26E-9CEE2B56D324 Q28074097-616708F7-3526-4FAE-BF60-7F5250777E61 Q28076600-4D9384A1-C2AA-4BE1-AB5C-E36ED1CDB239 Q28080256-25146DF1-C5B7-4EF6-B9B0-BA27F88B8CE9 Q28083100-04E46A3F-AA7F-4C8F-ACEE-36429E7A0A97 Q28534878-D3B66E2C-D953-4DB6-A719-B4535B24A7DB Q28545799-A43978AC-6B39-497A-A711-B810E9DC8FA2 Q28547386-493A01C4-ABB5-4BEA-A033-5790028BBF41 Q28658627-6775B13B-8D93-44FF-BA27-2D87091A26C4 Q28943418-9CF59926-734C-48E6-87E6-4D4DBCBAB0C7 Q30238992-55F5EE33-D82D-4D78-8444-31579475C8FE Q30240144-30CE680F-128C-4AA8-A123-869748D55B5C Q30371340-87584716-A7EC-4010-A039-901F86CF0E03 Q30400366-8EB1DF42-42EB-4A90-B551-1EE2C6A7FD76 Q30408574-5AEAAA01-58D9-42BF-B9FB-FA1585782D52 Q30418816-96B77915-78C9-489A-9D78-D93CB658EB9E Q30814834-86AE5492-E318-406E-88FE-5066F3905890 Q30828357-3A50C88A-9251-47E4-AD34-87025D96AE32 Q30927447-D022311A-81EB-4E4E-924C-0AAE72974324 Q33572210-686FB038-3CDF-4864-8EFB-9ECB63279F42 Q33582530-D00E87F1-72D3-4D51-880B-AC6572C621ED Q33666857-F13AE8D0-6F6F-412A-B374-4428171C3D85 Q33788588-3FF6CCD2-8542-4591-B901-C9F508D335F9 Q33838407-B6437C9D-8C7B-4A8D-B024-05CED52B9A72 Q33838853-84070207-FCBB-43E7-9179-3CA6F82BC0AF Q33891714-67D4BEC3-2E1F-464A-A21C-C13B188BC78E Q34013280-29013AE2-32F0-414A-82CE-865EC466C58A

P2860

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

http://www.wikidata.org/entity/Q34172669

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@ast

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@en

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@nl

type

label

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@ast

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@en

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@nl

prefLabel

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@ast

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@en

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@nl

P1433

Q34172669-284B5C28-BB06-4E41-B668-B4C66DFE211B

P1476

Q34172669-C7B41375-0997-410E-B8C5-227EF0BAA513

P2093

Q34172669-0045582B-2392-4E09-A0BE-877ECF613CA2

Q34172669-33F31556-23DB-4998-9302-22ED1E2D42FB

Q34172669-4E5BA218-9E52-4647-AB95-F58D90778AB8

Q34172669-52C498CD-9656-42EF-832C-C70651DE69F6

Q34172669-5FCE9AD5-7325-4AD2-AF44-3847F98A48B1

Q34172669-613B6192-2E53-44A7-84B6-F9DDCA29C7D3

Q34172669-69844DED-E78C-4089-AB30-E637C28B4ECC

Q34172669-6C8D1391-200F-43E6-88F9-B22A6B1F6AE0

Q34172669-860E0FB7-7F27-4251-9879-98D77398DA05

Q34172669-86E412D5-FCC9-438F-B30F-EC617F1B5436

P2860

Q34172669-150A8E39-CAB1-46E2-9155-77BAA56D0338

Q34172669-1B0BCFE2-6A76-41CF-91B0-58300F2C7BB8

Q34172669-1C6440F1-B988-49FB-A1B3-C9B938FBEFC7

Q34172669-1CAFFE7B-247C-4568-9DDD-39BC727E20AD

Q34172669-1E2B5679-2CE5-4BEB-8D59-D17EC3D554D3

Q34172669-339A1252-9F0E-43B9-B402-7B8F533087C5

Q34172669-41DCDE92-9A4C-40E7-8AFE-ED3F7CEB843A

Q34172669-432852F4-A81E-492F-AF29-5D6603C1AD43

Q34172669-4920AAB6-123C-4A84-8DF2-FF5FC2936073

Q34172669-4D2D957E-F5F7-4415-AE3E-52DABEF07E83

P304

Q34172669-63A8AC59-2058-48D2-8750-2F6D3436756D

P31

Q34172669-915E67FC-C505-4256-B895-DB93A6A8C1C2

P356

Q34172669-E97C2845-F791-4641-A86E-4ED1C46EF78B

P407

Q34172669-720C6250-349A-41BF-B57F-62DB3F267F77

P433

Q34172669-2B8D8369-6394-44AB-86AB-6C88BE0CBC9F

P478

Q34172669-A91D6A4E-66FF-4C74-9E05-C702AC1C025F

P50

Q34172669-12EFD647-D9C4-4F25-BCA2-5C47748B3EB2

Q34172669-1D52927C-4771-4005-B4F4-F17048D0D526

Q34172669-368C34E6-80E2-4D4F-AE92-E6BA5C49BB8A

Q34172669-4AA93E53-3DA6-4D29-9216-039BC2F67071

Q34172669-51EADD43-AA68-446E-BEC8-04CE40BA10EF

Q34172669-70B5EF1B-7329-4416-AE03-CD72106CDDC5

Q34172669-7DE4D35B-ED00-4B64-96E6-E4566FCB95BF

P577

Q34172669-A6FB246B-6751-40EF-9E13-563387E6C846

P698

Q34172669-7565E294-ABB9-4B3B-88EF-FCA2B12CF5FC

P932

Q34172669-76A6D20D-BA4E-4A39-B9AF-11EC872E68A2

P356

P1433

The New England Journal of Medicine

P1476

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

@en

P2093

Ana Alfirevic

http://www.w3.org/2001/XMLSchema#string

B Kevin Park

http://www.w3.org/2001/XMLSchema#string

Chantal Depondt

http://www.w3.org/2001/XMLSchema#string

Dalia Kasperavičiūtė

http://www.w3.org/2001/XMLSchema#string

David B Goldstein

http://www.w3.org/2001/XMLSchema#string

Elijah Chaila

http://www.w3.org/2001/XMLSchema#string

Erin L Heinzen

http://www.w3.org/2001/XMLSchema#string

Gerard D O'Connor

http://www.w3.org/2001/XMLSchema#string

John J Farrell

http://www.w3.org/2001/XMLSchema#string

Kevin V Shianna

http://www.w3.org/2001/XMLSchema#string

P2860

MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes

PLINK: a tool set for whole-genome association and population-based linkage analyses

Haploview: analysis and visualization of LD and haplotype maps

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Medical genetics: a marker for Stevens-Johnson syndrome

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

T-cell involvement in drug-induced acute generalized exanthematous pustulosis

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.

Human leukocyte antigen-A, -B, and -DRB1 haplotypes of cord blood units in the Tzu Chi Taiwan Cord Blood Bank.

P304

1134-1143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1013297

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

364

http://www.w3.org/2001/XMLSchema#string

P50

Munir Pirmohamed

Mary Carrington

Krishna Chinthapalli

Gianpiero L. Cavalleri

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21428769

http://www.w3.org/2001/XMLSchema#string

P932

3113609

http://www.w3.org/2001/XMLSchema#string